> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Abbott Proclaim Plus System
- URL: https://www.fdaweb.com/fda-approves-abbott-proclaim-plus-system/
- Published: 2022-08-25T12:00:00.000Z
- Updated: 2026-09-14T17:57:18.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152595

FDA has approved Abbott’s Proclaim Plus spinal cord stimulation system that the company says builds on its proprietary BurstDR stimulation. A company [statement](https://www.prnewswire.com/news-releases/fda-approves-abbotts-new-spinal-cord-stimulation-device-provides-tailored-relief-to-multiple-pain-areas-and-adds-more-treatment-options-for-evolving-pain-conditions-301610549.html?ref=fdaweb.com) says the system features FlexBurst360 therapy that offers pain coverage across up to six areas of the trunk and/or limbs and enables programming that can be adjusted as a person’s therapeutic needs evolve.

BurstDR therapy is described as Abbott’s exclusive stimulation technology that delivers pulses or bursts of mild electrical energy to alter pain signals as they travel from the spinal cord to the brain.